Table 1. Maximum CMV antigenemia and duration of CMV infection in patients with positive, negative, and indeterminate initial QuantiFERON-CMV results measured during the early phase of the first CMV infection post allogeneic HSCT.
Initial QuantiFERON-CMV results | P | |||
---|---|---|---|---|
Positive (N = 4) | Negative (N = 4) | Indeterminate (N = 8) | ||
Maximum CMV antigenemia (N/200,000 WBCs) | 16 (10–36) | 8 (1–28) | 20 (2–720) | 0.421 |
Duration of CMV infection (days) | 20 (11–56) | 16 (12–35) | 19.5 (5–47) | 0.740 |
Data are expressed as median (range).
Abbreviations: CMV, cytomegalovirus; HSCT, hematopoietic stem cell transplantation; WBCs, white blood cells.